HARROW, INC. — Director's Dealing 2023

Jan 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2023-01-02

Reporting Person: BOLL ANDREW R. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-02	Common Stock	M	23000	—	Acquired	278063	Direct
2023-01-02	Common Stock	F	9602	$14.76	Disposed	268461	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-02	Restricted Stock Unit	$0	M	23000	Disposed		Common Stock (23000)	Direct

Footnotes

F1: The listed Acquired (as described in the table above) 23,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Boll under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs vested in full on January 2, 2023, the third-year anniversary of the grant of the same, and settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 9,602 shares of Harrow common stock were not sold by Mr. Boll in any transaction; rather, they were shares of Harrow common stock withheld from the same aforementioned 23,000 share RSU issuance, by the Company, for payroll tax purposes only.